Boussageon Rémy
@BoussageonR
Followers
638
Following
2K
Media
22
Statuses
5K
Professeur Universitaire de Médecine Générale, Lyon 1. Médecin Généraliste PhD, philosophie de la medecine Aucun conflit d'intérêt.
Joined December 2018
REB project is published. Thanks to the team! @NaudetFlorian
@cucherat
@FranoisGueyffi2
@Doc_BBee
https://t.co/L7LyivP0BR
em-consulte.com
Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients
2
5
34
🆕 UBC TI Therapeutics Letter 159 🆕 Escitalopram vs citalopram https://t.co/iRsQRH56zn ✅ Citalopram best choice for most new prescriptions ✅ Citalopram costs less + works just as well #BetterPrescribing #prescribing #MedEd #antidepressants
1
0
3
@RWJE_BA @elmir1omerovic @yudapearl @AdanBecerraPhD @GreggWStone @xyu_shi @GiulioGrossi @kaulcsmc @stephensenn @drjohnm @VPrasadMDMPH RWE is a truly bullshit term. The real world simply does not provide evidence about what would have happened to a patient had they received a different treatment from the one they received, except in cases (that are almost nonexistent) where treatment choices are dictated.
15
29
102
Unpopular opinion Une des manières d'améliorer la #SantéMentale des personnes en situation de précarité... est d'améliorer leurs conditions de vie. Et pour cela, pas forcément besoin de services de psychiatrie. Parfois juste besoin d’un toit, d’un revenu, d’un peu de dignité
#SanteMentale | Les personnes en situation de précarité ont trois fois plus de risque de faire une tentative de suicide que les personnes aisées. Ce constat souligne l’impact profond des inégalités sociales sur la santé mentale et la nécessité de renforcer la prévention,
6
28
109
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis - The Lancet https://t.co/pQw1ybT9Df
@TheLancet
thelancet.com
We found strong evidence that antidepressants differ markedly in their physiological effects, particularly for cardiometabolic parameters. Treatment guidelines should be updated to reflect differen...
1
2
12
Despite their frequent use, opioids have limited benefits in managing noncancer pain (seen in figure). For acute musculoskeletal pain, opioids have a small mean effect in reducing pain (a decrease of <10 points on a scale of 0 to 100, with 0 indicating no pain and 100 worst pain)
8
40
169
En résumé (1/4 ): 1) la metformine ne "marche" dans rien. 2) le liraglutide devient le MaxiMir en prévention secondaire CV 3) les recommandations pour la prescription d'AB en soins primaires ne sont validées...
#DragiWebdo n°503 : asthme/activité physique, liraglutide/AVC, hémorroïdes, ostéoporose, vitamine D, rapport albuminurie/créatininurie, grossesse/TCC, metformine/AOMI, EBM https://t.co/zR9Qg4FDLW
3
2
5
#DragiWebdo n°503 : asthme/activité physique, liraglutide/AVC, hémorroïdes, ostéoporose, vitamine D, rapport albuminurie/créatininurie, grossesse/TCC, metformine/AOMI, EBM https://t.co/zR9Qg4FDLW
9
7
38
Presented at #AHA25: In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results:
0
162
373
Presented at #AHA25: In a meta-analysis of 17,801 patients with myocardial infarction and preserved LVEF (≥50%), beta-blockers did not reduce death, MI, or heart failure over a median 3.6 years of follow-up. Full results: https://t.co/1LiJFFvnm3
@AHAScience
7
236
569
I think we should be providing a disclaimer “very high risk” 33% had prior coronary revasc, 10% severe carotid disease or revasc, and 10% demonstrated PAD. It’s not a primary prevention trial
VESALIUS a star of this lipid session at #AHA25. Substantial and deeply clinically meaningful benefit w Repatha in primary prevention. Baseline LDL-C 122. Notable ARRs, and 20% decrease in all-cause mortality! #AHA25
11
12
107
Wow. Huge effect of fish oil on CVD outcomes for patients on hemodialysis! ‼️43% reduction in serious cardiac events ❗Significant reductions in many 2ry end points too 🐟 Standard-ish fish oil (1.6 g EPA/0.8 g DHA) 🌽 Versus corn oil placebo https://t.co/QMyeS7Ju9E
nejm.org
Cardiovascular disease is the leading cause of death in patients receiving hemodialysis, yet effective preventive therapies remain limited. Supplementation with n−3 polyunsaturated fatty acids, esp...
31
58
242
Surprising....😅 Dry cupping therapy has no effect on pain, function, or quality of life in women with knee osteoarthritis: Randomized placebo-controlled trial https://t.co/tDZ6Nsqzl2
8
33
154
To all those who still believe that payments made by the pharmaceutical industry do not influence doctors: two posts by Carl Heneghan and Tom Jefferson paint a well-documented picture of the situation, backed up by figures. The result is both enlightening and sickening. 1/
1
2
3
10/12 Ils ne l'ont pas fait car les experts, largement sponsorisés par Sanofi, ont décidé, contre toute logique 1) que 30 % d'efficacité chez les seniors, ça suffisait, 2) que ce n'était pas possible (trop de biais), 3) que ce n'était pas éthique,
2
1
1
11/12 Or, il est possible de mener de tels essais, même des experts payés par l'industrie des vaccins l'ont écrit ( https://t.co/RJgoGYSvqG)
1
1
2
L'EBM est un mythe : nième exemple : https://t.co/vRKUNQnsKk
1
1
1
